Yannan Jia

机构：The University of Texas MD Anderson Cancer Center, Shanghai Jiao Tong University, Chinese Academy of Medical Sciences & Peking Union Medical College, Shanghai First People's Hospital, Institute of Hematology & Blood Diseases Hospital, Shanghai Children's Hospital · ORCID：0000-0002-9192-7463

发表论文 70 篇 · 总被引 1158 次 · h-index 13

代表论文

• Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells (2023 · Haematologica · 被引 71)
• Efficacy of a novel BCL-xL degrader, DT2216, in preclinical models of JAK2 -mutated post-MPN AML (2025 · Blood · 被引 22)
• FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML (2023 · Leukemia · 被引 19)
• Study on natural frequency response characteristics of coal vibration excited by simple harmonic wave (2022 · Scientific Reports · 被引 11)
• Azacitidine combined with interferon‐α for pre‐emptive treatment of AML / MDS after allogeneic peripheral blood stem cell transplantation: A prospective phase II study (2024 · British Journal of Haematology · 被引 6)
• Improved survival in older patients with myeloid malignancies undergoing haploidentical peripheral blood stem cell transplantation with low-dose anti-thymocyte globin (ATG)/post-cyclophosphamide (PTCy)-based regimen for graft-versus-host disease prophylaxis (2025 · Annals of Hematology · 被引 5)